Latest News about GMAB
Recent news which mentions GMAB
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
November 09, 2023
From InvestorPlace
United Airlines, Interactive Brokers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
October 18, 2023
From Benzinga
Quant Ratings Updated on 92 Stocks
October 17, 2023
From InvestorPlace
Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher
September 26, 2023
From InvestorPlace
Why Shares of Iovance Biotherapeutics Dropped Thursday
September 14, 2023
From Motley Fool
AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst
September 11, 2023
From Benzinga
Why Shares of Zai Lab Limited Were Jumping on Tuesday
September 05, 2023
From Motley Fool
Encouraging Data From Seagen/Genmab's Cervical Cancer Study - Tivdak Success Sets Stage For New Indications
September 05, 2023
From Benzinga
The 3 Most Promising Biotech Stocks to Own Now
August 31, 2023
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2023
August 24, 2023
From Benzinga
Is AbbVie Still a Good Dividend Stock to Buy?
August 08, 2023
From Motley Fool
From Motley Fool
From InvestorPlace
3 Biotech Stocks That AI is Loving in July
July 12, 2023
From InvestorPlace
From Motley Fool
Genmab/AbbVie's Blood Cancer Treatment Shows 82% Response Rate In Pretreated Follicular Lymphoma Patients
June 28, 2023
From Benzinga
FDA Approves AbbVie/Genmab's Cancer Drug As First Bispecific Antibody For Type Of Lymphoma In Adult Patients
May 19, 2023
From Benzinga
Focus On Genmab's Pipeline If Darzalex Arbitration with Janssen Goes Sideways: Analyst
April 24, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.